Argenx Se ARGX
NASDAQ ARGX
$929.07 +34.30 (+3.83%)
As of: Nov 6, 2026 · 3:59 PM EST

Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020)

Updated

Argenx Se's Current Deferred Revenue came in at $316.11 million for Q4 2020, down 2.8% from $325.28 million a year earlier.

Analysis

Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020) Analysis & Trends

Going back to Q4 2015, Argenx Se's Current Deferred Revenue data covers 10 quarters.

  • Current Deferred Revenue carries a five-year compound annual growth rate of 133.8% (FY2015 to FY2020).
  • Going back by year, Current Deferred Revenue was $325.28 million in FY2019, $2.47 million in FY2018 (-83.7%), $15.19 million in FY2017 (-28.7%) and $21.29 million in FY2016 (+370.3%).
  • The five-year range for quarterly Current Deferred Revenue is $2.27 million (Q2 2019) to $325.28 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Argenx Se 56.96 Bn 56.96 Bn 1.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 316.11 Mn
Jun 30, 2020 75.69 Mn
Dec 31, 2019 325.28 Mn
Jun 30, 2019 2.27 Mn
Dec 31, 2018 2.47 Mn
Jun 30, 2018 5.68 Mn
Dec 31, 2017 15.19 Mn
Jun 30, 2017 24.68 Mn
Dec 31, 2016 21.29 Mn
Dec 31, 2015 4.53 Mn
API Access

Argenx Se Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY